Charles C. Berry

University of California, San Diego — United States

Medicine · Health Sciences

70h-index27.0kcitations194works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Obesity, Physical Activity, Diet(25), CRISPR and Genetic Engineering(20), Smoking Behavior and Cessation(16), HIV Research and Treatment(16), Virus-based gene therapy research(16)

Publications194 total

Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome
Blood·2023· 37 citedOpen Access
ECG findings in BPaL-based TB treatment regimens: the geographical effect on QT prolongation
2023Open Access
G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential
Viruses·2022· 11 citedOpen Access
Challenges in estimating numbers of vectors integrated in gene-modified cells using DNA sequence information
Molecular Therapy·2021· 13 citedOpen Access
Pilot study of the multicentre DISCHARGE trial: image quality and protocol adherence results of computed tomography and invasive coronary angiography (vol 30, pg 1997, 2020)
European Radiology·2020
INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions
Molecular Therapy — Methods & Clinical Development·2016· 89 citedOpen Access
INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes
Molecular Therapy — Methods & Clinical Development·2016· 127 citedOpen Access
a Diversity of Human Hematopoietic Differentiation Programs Identified through In Vivo Tracking of Hematopoiesis in Wiskott-Aldrich Syndrome Patients
Blood·2016
754. Exploring the Human Hematopoietic Hierarchy Through Retroviral Integration Sites Tracking in the Wiskott Aldrich Syndrome Gene Therapy Trial
Molecular Therapy·2016Open Access
Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
JAMA·2015· 374 citedOpen Access
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
New England Journal of Medicine·2014· 402 citedOpen Access
Comparing DNA integration site clusters with scan statistics
Bioinformatics·2014· 26 citedOpen Access
HIV latency and integration site placement in five cell-based models
Retrovirology·2013· 114 citedOpen Access
134 HIV DNA Integration
JAIDS Journal of Acquired Immune Deficiency Syndromes·2012
Estimating abundances of retroviral insertion sites from DNA fragment length data
Bioinformatics·2012· 135 citedOpen Access
HTLV-1 clonality during chronic infection and BLV clonality during primary infection
Retrovirology·2011· 1 citedOpen Access
Abstract 2715: Host genomic environment determines HTLV-1 clone size <i>in vivo</i>
Cancer Research·2011
A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
Nucleic Acids Research·2011· 71 citedOpen Access
HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
PLoS Pathogens·2011· 207 citedOpen Access
The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones
Blood·2011· 318 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Frederic D. Bushman(16), Nirav Malani(7), Joseph R. Ecker(6), James F. Sallis(6), Philip R. Nader(6), Paul Shinn(5), Detlef Weigel(5), Shelia L. Broyles(5), Robert M. Kaplan(4), Marina Cavazzana(4), Justin Borevitz(4), Joanne Chory(4), John P. Pierce(4), Thomas L. McKenzie(4), Huaming Chen(3), Salima Hacein‐Bey‐Abina(3), Apiradee Lim(3), Capucine Pïcard(3), Gary P. Wang(3), Alain Fischer(3)